HEPATITIS C TREATMENT OF RENAL TRANSPLANT AND CHRONIC KIDNEY DISEASE PATIENTS: EFFICACY AND SAFETY OF DIRECT-ACTING ANTIVIRAL REGIMENS CONTAINING SOFOSBUVIR.
Fernanda Bellini Lunardi MichelsAna Cristina de Castro Amaral FeldnerRoberto José de Carvalho-FilhoGustavo de Almeida VieiraAna Lucia da Silva SouzaMaria Lucia Cardoso Gomes FerrazPublished in: Arquivos de gastroenterologia (2020)
The direct-acting antivirals were safe and efficacious in CKD patients treated with SOF-containing regimens, with the observation of high SVR rates, good tolerability and few severe adverse events. The combination with ribavirin increased the risk of anemia and the administration of escalating doses seems to be useful in patients with GFR <60 mL/min. In patients with GFR <30 mL/min, SOF had no significant renal impact, with serum creatinine returning to levels close to baseline after treatment.